估算尼泊尔管理和护理 2 型糖尿病的医疗开支:患者视角。

IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES
MDM Policy and Practice Pub Date : 2023-12-14 eCollection Date: 2023-07-01 DOI:10.1177/23814683231216938
Padam Kanta Dahal, Lal Rawal, Zanfina Ademi, Rashidul Alam Mahumud, Grish Paudel, Corneel Vandelanotte
{"title":"估算尼泊尔管理和护理 2 型糖尿病的医疗开支:患者视角。","authors":"Padam Kanta Dahal, Lal Rawal, Zanfina Ademi, Rashidul Alam Mahumud, Grish Paudel, Corneel Vandelanotte","doi":"10.1177/23814683231216938","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background.</b> This study aimed to estimate the health care expenditure for managing type 2 diabetes (T2D) in the community setting of Nepal. <b>Methods.</b> This is a baseline cross-sectional study of a heath behavior intervention that was conducted between September 2021 and February 2022 among patients with T2D (<i>N</i> = 481) in the Kavrepalanchok and Nuwakot districts of Nepal. Bottom-up and micro-costing approaches were used to estimate the health care costs and were stratified according to residential status and the presence of comorbid conditions. A generalized linear model with a log-link and gamma distribution was applied for modeling the continuous right-skewed costs, and 95% confidence intervals were obtained from 10,000 bootstrapping resampling techniques. <b>Results.</b> Over 6 months the mean health care resource cost to manage T2D was US $22.87 per patient: 61% included the direct medical cost (US $14.01), 15% included the direct nonmedical cost (US $3.43), and 24% was associated with productivity losses (US $5.44). The mean health care resource cost per patient living in an urban community (US $24.65) was about US $4.95 higher than patients living in the rural community (US $19.69). The health care costs per patient with comorbid conditions was US $22.93 and was US $22.81 for those without comorbidities. Patients living in rural areas had 16% lower health care expenses compared with their urban counterparts. <b>Conclusion.</b> T2D imposes a substantial financial burden on both the health care system and individuals. There is a need to establish high-value care treatment strategies for the management of T2D to reduce the high health care expenses.</p><p><strong>Highlights: </strong>More than 60% of health care expenses comprise the direct medical cost, 15% direct nonmedical cost, and 24% patient productivity losses. The costs of diagnosis, hospitalization, and recommended foods were the main drivers of health care costs for managing type 2 diabetes.Health care expenses among patients living in urban communities and patients with comorbid conditions was higher compared with those in rural communities and those with without comorbidities.The results of this study are expected to help integrate diabetes care within the existing primary health care systems, thereby reducing health care expenses and improving the quality of diabetes care in Nepal.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"8 2","pages":"23814683231216938"},"PeriodicalIF":1.9000,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725113/pdf/","citationCount":"0","resultStr":"{\"title\":\"Estimating the Health Care Expenditure to Manage and Care for Type 2 Diabetes in Nepal: A Patient Perspective.\",\"authors\":\"Padam Kanta Dahal, Lal Rawal, Zanfina Ademi, Rashidul Alam Mahumud, Grish Paudel, Corneel Vandelanotte\",\"doi\":\"10.1177/23814683231216938\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background.</b> This study aimed to estimate the health care expenditure for managing type 2 diabetes (T2D) in the community setting of Nepal. <b>Methods.</b> This is a baseline cross-sectional study of a heath behavior intervention that was conducted between September 2021 and February 2022 among patients with T2D (<i>N</i> = 481) in the Kavrepalanchok and Nuwakot districts of Nepal. Bottom-up and micro-costing approaches were used to estimate the health care costs and were stratified according to residential status and the presence of comorbid conditions. A generalized linear model with a log-link and gamma distribution was applied for modeling the continuous right-skewed costs, and 95% confidence intervals were obtained from 10,000 bootstrapping resampling techniques. <b>Results.</b> Over 6 months the mean health care resource cost to manage T2D was US $22.87 per patient: 61% included the direct medical cost (US $14.01), 15% included the direct nonmedical cost (US $3.43), and 24% was associated with productivity losses (US $5.44). The mean health care resource cost per patient living in an urban community (US $24.65) was about US $4.95 higher than patients living in the rural community (US $19.69). The health care costs per patient with comorbid conditions was US $22.93 and was US $22.81 for those without comorbidities. Patients living in rural areas had 16% lower health care expenses compared with their urban counterparts. <b>Conclusion.</b> T2D imposes a substantial financial burden on both the health care system and individuals. There is a need to establish high-value care treatment strategies for the management of T2D to reduce the high health care expenses.</p><p><strong>Highlights: </strong>More than 60% of health care expenses comprise the direct medical cost, 15% direct nonmedical cost, and 24% patient productivity losses. The costs of diagnosis, hospitalization, and recommended foods were the main drivers of health care costs for managing type 2 diabetes.Health care expenses among patients living in urban communities and patients with comorbid conditions was higher compared with those in rural communities and those with without comorbidities.The results of this study are expected to help integrate diabetes care within the existing primary health care systems, thereby reducing health care expenses and improving the quality of diabetes care in Nepal.</p>\",\"PeriodicalId\":36567,\"journal\":{\"name\":\"MDM Policy and Practice\",\"volume\":\"8 2\",\"pages\":\"23814683231216938\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-12-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725113/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MDM Policy and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/23814683231216938\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MDM Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23814683231216938","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

研究背景本研究旨在估算在尼泊尔社区环境中管理 2 型糖尿病(T2D)的医疗支出。研究方法这是一项基线横断面研究,研究对象是 2021 年 9 月至 2022 年 2 月期间在尼泊尔 Kavrepalanchok 和 Nuwakot 县的 2 型糖尿病患者(N = 481)中开展的健康行为干预。采用自下而上和微观成本计算方法估算医疗成本,并根据居住状况和是否存在合并症进行分层。采用对数链接和伽马分布的广义线性模型对连续右偏成本进行建模,并通过 10,000 次引导重采样技术获得 95% 的置信区间。研究结果在 6 个月的时间里,每位患者管理 T2D 的平均医疗资源成本为 22.87 美元:61% 包括直接医疗成本(14.01 美元),15% 包括直接非医疗成本(3.43 美元),24% 与生产力损失有关(5.44 美元)。居住在城市社区的每位患者的平均医疗资源成本(24.65 美元)比居住在农村社区的患者(19.69 美元)高出约 4.95 美元。有合并症的患者人均医疗费用为 22.93 美元,无合并症的患者人均医疗费用为 22.81 美元。农村地区患者的医疗费用比城市患者低 16%。结论T2D 给医疗系统和个人都带来了巨大的经济负担。有必要为治疗 T2D 制定高价值的护理治疗策略,以降低高昂的医疗费用:超过 60% 的医疗费用包括直接医疗成本、15% 的直接非医疗成本和 24% 的患者生产力损失。诊断、住院和推荐食物的费用是管理 2 型糖尿病医疗费用的主要驱动因素。城市社区患者和有合并症的患者的医疗费用高于农村社区患者和无合并症的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Estimating the Health Care Expenditure to Manage and Care for Type 2 Diabetes in Nepal: A Patient Perspective.

Background. This study aimed to estimate the health care expenditure for managing type 2 diabetes (T2D) in the community setting of Nepal. Methods. This is a baseline cross-sectional study of a heath behavior intervention that was conducted between September 2021 and February 2022 among patients with T2D (N = 481) in the Kavrepalanchok and Nuwakot districts of Nepal. Bottom-up and micro-costing approaches were used to estimate the health care costs and were stratified according to residential status and the presence of comorbid conditions. A generalized linear model with a log-link and gamma distribution was applied for modeling the continuous right-skewed costs, and 95% confidence intervals were obtained from 10,000 bootstrapping resampling techniques. Results. Over 6 months the mean health care resource cost to manage T2D was US $22.87 per patient: 61% included the direct medical cost (US $14.01), 15% included the direct nonmedical cost (US $3.43), and 24% was associated with productivity losses (US $5.44). The mean health care resource cost per patient living in an urban community (US $24.65) was about US $4.95 higher than patients living in the rural community (US $19.69). The health care costs per patient with comorbid conditions was US $22.93 and was US $22.81 for those without comorbidities. Patients living in rural areas had 16% lower health care expenses compared with their urban counterparts. Conclusion. T2D imposes a substantial financial burden on both the health care system and individuals. There is a need to establish high-value care treatment strategies for the management of T2D to reduce the high health care expenses.

Highlights: More than 60% of health care expenses comprise the direct medical cost, 15% direct nonmedical cost, and 24% patient productivity losses. The costs of diagnosis, hospitalization, and recommended foods were the main drivers of health care costs for managing type 2 diabetes.Health care expenses among patients living in urban communities and patients with comorbid conditions was higher compared with those in rural communities and those with without comorbidities.The results of this study are expected to help integrate diabetes care within the existing primary health care systems, thereby reducing health care expenses and improving the quality of diabetes care in Nepal.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
MDM Policy and Practice
MDM Policy and Practice Medicine-Health Policy
CiteScore
2.50
自引率
0.00%
发文量
28
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信